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Abstract
The filamentous fungus Lomentospora (Scedosporium) prolificans is an emerging oppor-
tunistic pathogen associated with fatal infections in patients with disturbed immune func-
tion. Unfortunately, conventional therapies are hardly of any use against this fungus due
to its intrinsic resistance. Therefore, we performed an integrated study of the L. prolificans
responses to the first option to treat these mycoses, namely voriconazole, with the aim of
unveiling mechanisms involved in the resistance to this compound. To do that, we used a
wide range of techniques, including fluorescence and electron microscopy to study mor-
phological alterations, ion chromatography to measure changes in cell-wall carbohydrate
composition, and proteomics-based techniques to identify the proteins differentially
expressed under the presence of the drug. Significantly, we showed drastic changes
occurring in cell shape after voriconazole exposure, L. prolificans hyphae being shorter
and wider than under control conditions. Interestingly, we proved that the architecture and
carbohydrate composition of the cell wall had been modified in the presence of the drug.
Specifically, L. prolificans constructed a more complex organelle with a higher presence
of glucans and mannans. In addition to this, we identified several differentially expressed
proteins, including Srp1 and heat shock protein 70 (Hsp70), as the most overexpressed
under voriconazole-induced stress conditions. The mechanisms described in this study,
which may be directly related to L. prolificans antifungal resistance or tolerance, could be
used as targets to improve existing therapies or to develop new ones in order to success-
fully eliminate these mycoses.
Introduction
The filamentous fungus Lomentospora prolificans, formerly known as Scedosporium prolificans
[1], is an opportunistic pathogen producing mycoses with a wide range of clinical manifesta-
tions, from superficial to deep infections. Importantly, when patients suffer from deep immu-
nosuppression, L. prolificans tends to disseminate through the bloodstream due to its capacity
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to give rise to conidia inside body fluids and tissues, this infection pattern being the most dan-
gerous and fatal [2].
As a consequence of the increase in the number of immunocompromised population over
the last few decades, the prevalence of this species, along with the genus Scedosporium, is rising
in several countries [3,4]. Thus, these fungi are becoming relevant emerging pathogens. In
addition, these species are typically recovered from the respiratory tracts of cystic fibrosis
patients, L. prolificans being among the most prevalent species in Australian [5,6] and Spanish
[7] clinical settings. However, the most important feature of L. prolificans is its inherent resis-
tance to virtually all currently available antifungal compounds, showing very low susceptibility
patterns [8]. In consequence, infections caused by this species are associated with high morbid-
ity and mortality rates [9].
Among the main classes of systemic antifungal drugs, azoles have been shown to be the
most effective against L. prolificans, especially voriconazole (VRC), either alone or in combi-
nation with other compounds, such as terbinafine [10]. In fact, this triazole is the first-line
treatment, as well as surgical debridement of the infected tissue when possible [11]. However,
MICs observed in in vitro studies are unacceptably high (4->16 μg/ml) [8], with these con-
centrations in patients being difficult to achieve [9]. Moreover, although clinical response to
treatment with VRC is better in comparison to other antifungal drugs, such as polyenes or
echinocandins, disease outcomes are still poor [12,2]. Therefore, there is an increasing need
for the development of new methods to manage L. prolificans infections.
In this sense, the cell wall represents one of the most interesting target organelles in fun-
gal cells to help extend the range of therapeutic strategies. On the one hand, its specific com-
position and structure, completely absent in mammalian cells, reduces drug-associated
toxicity and side-effects on host cells. On the other hand, molecular targets that make up
this structure are highly available for antifungal compounds. Consequently, the identifica-
tion of cell wall structures or molecules involved in antifungal resistance or pathobiology
can be proposed as novel targets for developing truly effective therapies against these
mycoses.
Consequently, in this work, we performed an integrated study of the changes occurring in
L. prolificans cells when exposed to VRC. More specifically, changes in the cell wall architec-
ture and composition were analysed, with special attention paid to the cell surface carbohy-
drates and subproteome. We were therefore able to identify several mechanisms and
molecules that may be related to VRC resistance in this pathogenic fungus, which can be tested
as new targets in the treatment of L. prolificans infections.
Materials and methods
Fungal strain, culture conditions, and germination assays
The L. prolificans strain CECT 20842, which showed MIC > 16 μg/ml for VRC in a previous
analysis in our laboratory, was the subject of this research. In order to determine L. prolificans
germination rates, conidia from 7-day old cultured potato dextrose agar (PDA) (Pronadisa,
Madrid, Spain) were obtained, these were filtered through gauze, and the cell density deter-
mined using a counting chamber. Then, 5×105 spores/ml were inoculated in potato dextrose
broth (PDB) (Pronadisa) in the presence of 2 or 4 μg/ml of VRC (Sigma-Aldrich, St Louis,
MO, USA), and incubated for 9 h at 37˚C, 120 rpm, adding the same volume of DMSO in con-
trol flasks. At hourly intervals, 200 μl samples were obtained and fixed with 20 μl of 10% form-
aldehyde. At least one hundred cells per experimental time and condition were counted, and
their germination rates determined. Three assays with technical triplicates were performed to
ensure statistical significance.
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To measure the rest of the parameters considered in this study, L. prolificans cells were har-
vested by centrifugation (5 min, at 4,500 g) after 9 h of culture alone or in the presence of 2 μg/
ml of VRC, except when noted, and washed twice with PBS (50 mM, pH 7.5).
Cell morphology analysis and indirect determination of chitin content by
calcofluor white staining
Fungal cells exposed for 9 h to 0, 2, or 4 μg/ml of VRC were air-dried on slides overnight at
37˚C before fixation with acetone for 20 min. Next, calcofluor white (40 ng/ml) was added for
20 min, dye excess being washed away with three applications of PBS. Finally, cells were visual-
ised by a Zeiss Axioskop fluorescence microscope (Oberkochen, Germany), and micrographs
analysed by ImageJ software (http://imagej.nih.gov/ij/) to quantify the emitted fluorescence,
and cell morphological parameters. Three biological replicates were performed, at least one
hundred cells being examined under the microscope each time.
Transmission electron microscopy
To visualize fungal tissue under the electron microscope, cells were fixed with 2% glutaralde-
hyde in So¨renson buffer (SB) for 4h, washed with 6% sucrose in SB and postfixed in 1% OsO4
for 1 h at 4˚C. Cells were washed with SB and dehydrated through an acetone series. Next,
samples were embedded using the Epoxy Embedding Medium kit (Sigma-Aldrich). Semithin
sections were obtained using a Leica UCT Ultramicrotome (Leica, Wetzlar, Germany), and
then stained with toluidine blue. Ultrathin sections were contrasted with uranyl acetate and
lead citrate. Electron micrographs were obtained using a transmission electron microscope
Philips CM120 at 100 kV (Koninklijke Philips Electronics, Amsterdam, The Netherlands). All
incubations were performed at room temperature, except when noted. After image acquisition,
measurements of the thickness of the cell wall layers were performed using the ImageJ software
in at least 20 cells per condition, quantifying 10 areas of each cell [13].
Compositional analysis of whole cell wall and cell surface carbohydrates
To determine VRC-induced variations in the composition of the cell wall, we analysed both
the carbohydrate composition of the whole organelle and those linked to cell surface-associ-
ated proteins (CSP). To measure the former, cells were washed three times with cold distilled
H2O, resuspended in 10 mM Tris-HCl (pH 8), and disrupted by using glass beads and a Mill-
Mix 20 bead beater (Tehtnica, Slovenia) for 20 min at 30 Hz. Supernatants were recovered,
and centrifuged 5 min at 3,800 g, then pellet washed five times with cold distilled H2O. Next,
acid-based degradation of polysaccharides was carried out, as previously reported [14].
Briefly, 75 μl of 72% (v/v) H2SO4 per mg of cell walls were added, samples being left at room
temperature for 3 h. Then cold distilled H2O was added little by little to achieve 1 M H2SO4,
with the samples transferred to sealed glass tubes later, and incubated at 100˚C for 3 h. After-
wards, samples were cooled, neutralised using saturated Ba(OH)2, and centrifuged 5 min at
3,800 g.
To obtain CSP, intact fungal cells were boiled in extraction buffer (50 mM Tris-HCl pH
8.0, 0.1 M EDTA, 2% [w/v] SDS, 10 mM DTT) for 10 min, as previously reported by Pitarch
and co-workers [15]. Then, H2SO4 was added to the samples to achieve an acid concentra-
tion of 1 M, followed by the protocol mentioned above, for carbohydrate chemical lysis from
this step.
After carbohydrate extraction, a semi-quantitative determination of the content of the cell
wall in rhamnose, arabinose, glucosamine, galactose, glucose, and mannose was carried out
by high-performance anion-exchange chromatography with pulsed amperometric detection
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(HPAEC-PAD) using CarboPac PA-10 columns and the chromatography system Dionex-
600 (Thermo Scientific, Rockford, IL, USA). Peak area values for each monosaccharide were
normalized using cell wall dry weights and compared between VRC-treated and control
cells.
Analysis of the effect of cell membrane- and wall-disturbing agents
L. prolificans conidia were obtained as previously mentioned and fungal cell suspensions
adjusted to 107 conidia/ml. Two μl of 1/10 serial dilutions were spotted onto PDA agar plates
containing different concentrations of either VRC (0, 2 or 4 μg/ml), SDS, calcofluor white and
congo red (0, 100, 250, 500, 750 or 1000 μg/ml), or a combination of VRC with each stress-
inducing agent, as described elsewhere [16,17]. After two days at 37˚C the plates were exam-
ined and photographed so that any fungal growth could be analyzed.
Protein extraction and proteomic profiles of whole cell and cell surface-
associated proteins
In order to identify proteins related to antifungal drug resistance, proteomes and surfaceomes
of L. prolificans, exposed or not to VRC, were analysed as previously reported by our research
group [18]. Briefly, to obtain whole cell or CSP protein extracts, fungal cells were, as men-
tioned above, disrupted or boiled in extraction buffer, respectively, with the proteins being
precipitated by the TCA/Acetone method, and resuspended in rehydration buffer. Protein
concentration was determined using the Pierce 660 nm Protein Assay Reagent (Thermo
Scientific).
Proteomic profiles of both entire cells and CSP were resolved by two-dimensional electro-
phoresis (2-DE). First, 400 μg of fungal proteins dissolved in rehydration buffer were loaded
onto 18-cm-long Immobiline DryStrip pH 3–10 (GE Healthcare) with 1% (v/v) 2-mercap-
toethanol, 1% (v/v) ampholytes, and 0.002% (w/v) bromophenol blue for isoelectric focusing
(IEF). After an overnight rehydration step, IEF was performed as follows: 500 V for 2,000 Vhr,
1,000 V for 9,000 Vhr, 8,000 V for 20,000 Vhr, and 8,000 V for 100,000 Vhr; 50 μA per strip.
Then, two 15 min-long incubation steps in equilibration buffer (6 M urea, 75 mM Tris-HCl
pH 6.8, 25.5% [v/v] glycerol, 2% [w/v] SDS, 0.002% [w/v] bromophenol blue) were performed,
one with 1% (w/v) DTT and the other with 2.5% (w/v) iodoacetamide. Next, samples were sep-
arated by SDS-PAGE in a PROTEAN II xl Cell (Bio-Rad, Hercules, CA, USA) at 20 mA per
gel, under refrigerated conditions. After that, fungal proteins were stained with Coomassie
Brilliant Blue (CBB) and then gel images were acquired and analysed by using the ImageScan-
ner III (GE Healthcare) and ImageMaster 2D Platinum Software (GE Healthcare),
respectively.
Identification of differentially expressed proteins by mass spectrometry
The protein spots most differentially expressed were manually excised and submitted for pro-
tein identification by LC-MS/MS, performed exactly as described elsewhere [18]. Briefly,
selected SDS-PAGE spots were in-gel digested using trypsin (Roche, Basel, Switzerland) and
the peptide mixture was analysed using a SYNAPT HDMS mass spectrometer (Waters, Mil-
ford, MA) interfaced with a nanoAcquity UPLC System (Waters). Obtained spectra were pro-
cessed using VEMS [19] and searched for against the NCBI non-redundant (nr) database
restricted to Fungi (version 20150309) using the online MASCOT server (Matrix Science Ltd.,
London; http://www.matrixscience.com). Even though the L. prolificans genome has been
released it is not yet available publicly [20], so protein identification was performed by
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comparison with orthologous proteins from other fungi whose genomes were already available
in the NCBInr database.
Statistical analyses
Statistical analysis was performed using the GraphPad Prism 5 software (GraphPad Software,
CA, USA). Differences in the mean were analysed by using the Student’s paired or unpaired t-
test.
Results
Voriconazole-induced modifications on L. prolificans growth and
morphology
The exposure of L. prolificans to VRC did not affect fungal germination rates as hyphae
started to grow 3 h after inoculation and reached approximately 80% of germinated cells in
less than 8 h, in all the concentrations assessed (Fig 1A). In contrast, hyphal morphology was
drastically modified, as visualised microscopically (Fig 1B), showing that exposure to the
antifungal drug promoted a significant dose-dependent cell thickening and shortening (Fig
1C and 1D). Consequently, the total area occupied by fungal cells was not significantly modi-
fied (Fig 1E).
Moreover, calcofluor white allows the chitin content in fungal cells to be measured indi-
rectly. So, the results show that VRC-treated cells emitted more fluorescence than the controls,
this parameter being dependant on the VRC concentration; when the higher concentration
was applied it rose to a level that was more than two times higher (Fig 1F).
Fig 1. Morphological changes on Lomentospora prolificans cells caused by Voriconazole (VRC) exposure. Germination
assays (A) were performed to analyze the effect of VRC on fungal cells. After 9 h of incubation cells were stained with calcofluor white
and microscopically analysed (B) to determine their length (C), width (D), occupied area (E), and emitted fluorescence (F). Scale
bar = 5 μm. Results are shown as mean ± SEM, n = 4. **p<0.01, ***p<0.0001 compared to non-treated cells. a.u., arbitrary units.
https://doi.org/10.1371/journal.pone.0174885.g001
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Ultrastructural and compositional changes on L. prolificans cell wall
caused by voriconazole
Transmission electron microscopy was used to determine the structural changes in the fungal
cell wall under VRC-induced stress conditions. Thus, it was observed that cells treated with
the antifungal drug increased their overall cell wall thickness (Fig 2A), this fact is, above all,
due to a remarkable increase—almost three times—in the thickness of the fibrillar outer layer.
However, no significant changes were observed in the low electro-dense inner layer between
treated and untreated L. prolificans cells (Fig 2B).
On the other hand, the cell wall carbohydrate compositional analysis showed an overall
increase in carbohydrate abundance in VRC-treated cells in comparison with controls. Pre-
cisely, exposure to VRC induced changes in several monosaccharides in cell wall backbone,
with a significant increase in the rhamnose, glucosamine, glucose, and mannose content (Fig
3A). Moreover, when carbohydrate residues of CSP were scrutinised the rise was significant in
the cases of galactose, glucose, and mannose residues (Fig 3B). Remarkably, in both extracts
the most relevant changes occurred in the amounts of glucose and mannose. It is also worth
highlighting the fact that, although there were significant differences in the relative abundance
of the abovementioned specific monosaccharides, the increase in carbohydrate content was
proportional between control and antifungal drug-treated cells (Fig 3C and 3D).
Phenotypic analysis of the effect of voriconazole under cell membrane
and wall stress conditions
We performed L. prolificans spot assays in the presence of 100, 250, 500, 750 or 1000 μg/ml of
the membrane-disturbing detergent SDS, and wall-stressing agents calcofluor white and congo
Fig 2. Ultrastructural analysis of voriconazole-induced changes on Lomentospora prolificans cells. Transmission electron
microscopy images (A) and measurements of cell wall thickness (B) of non-treated and 2 μg/ml voriconazole-treated fungal cells.
Black lines highlight the thickness of the outer fibrillar layer. Results are shown as mean ± SEM, n 20 cells. ***p<0.0001 compared
to non-treated cells.
https://doi.org/10.1371/journal.pone.0174885.g002
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red to analyze the susceptibility of the fungus to these compounds (S1 Fig). Then the effect of
VRC during fungal cell membrane and wall stress conditions was evaluated by combining the
antifungal drug with each of the agents mentioned above. Interestingly, it was observed that
the presence of any of the three disturbing agents increased the effect of VRC on L. prolificans
cells, its colonies showing lower levels of viability and changes in the morphology of the colo-
nies when compared to the controls (Fig 4).
Differential protein abundance in L. prolificans cell surface-associated
proteins induced by voriconazole
Finally, we analysed the quantitative and qualitative changes occurring in fungal proteomes
and surfaceomes in response to VRC. Regarding the entire cell proteome, no significant
changes, either quantitative or qualitative, were observed when control and VRC-exposed cells
were compared (data not shown). Conversely, when surfaceomes were analysed up to seventy-
two protein spots were found to be differentially expressed between treated and non-treated
cell surfaceomes. Of these, forty protein spots were underexpressed and thirty-two overex-
pressed in VRC-treated cells, one of these only present after VRC exposure (Fig 5).
In order to focus on the most relevant proteins, eight protein spots were then identified: the
four most overexpressed (including the one only present in VRC-treated surfaceomes), and
the four most underexpressed in cells exposed to VRC, that is in comparison to control cells
(Table 1). From the first group, two protein spots were identified as heat shock protein (Hsp)
70, one as a glutamate dehydrogenase-like protein, and another one as a Srp1 family-like pro-
tein (Serine-rich RNA polymerase I suppressor protein), the latter being the protein spot that
only appeared when cells were exposed to VRC. Regarding the second group of protein spots,
two of them correspond to 60S ribosomal protein-like protein, and the other two were
Fig 3. Biochemical characterization of the carbohydrate composition of Lomentospora prolificans cell wall.
Carbohydrate compositional analysis of whole cell wall (A) and cell wall surface (B) upon exposure to 2 μg/ml
voriconazole. Results are shown as mean ± SEM, n = 3. *p<0.05 compared to non-treated cells. Percentage of
monosaccharide content in the whole cell wall (C) and surface (D).
https://doi.org/10.1371/journal.pone.0174885.g003
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identified as an inconclusive mixture of several proteins, including glyceraldehyde-3-phos-
phate dehydrogenase or RNA recognition domain-containing protein.
Discussion
The most challenging characteristic presented by L. prolificans is its inherent resistance to all
currently available systemically active antifungal drugs [8], infections caused by this fungus
being very difficult to manage and to eliminate. Of all the available antifungal drugs, the most
effective agent against L. prolificans cells is VRC which, in combination with terbinafine,
brings better results [10], suggesting that disturbing fungal cells in several ways may enhance
Fig 4. Effect of cell membrane- and wall-disturbing agents on Lomentospora prolificans in the
presence of voriconazole. Decimal dilutions of conidial suspensions were spotted onto potato dextrose agar
plates containing SDS (100 μg/ml), calcofluor white (500 μg/ml; CFW) or congo red (750 μg/ml; CR), and
combined with 0, 2 or 4 μg/ml of voriconazole (VRC).
https://doi.org/10.1371/journal.pone.0174885.g004
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Fig 5. Effect of voriconazole on proteomic profiles of the Lomentospora prolificans cell surface subproteome. Fungal cells
were grown in absence (A) or presence (B) of 2 μg/ml voriconazole, and their surfaceomes resolved by two-dimensional
electrophoresis. Arrows point to the most differentially expressed protein spots that were identified by LC-MS/MS (See Table 1).
https://doi.org/10.1371/journal.pone.0174885.g005
Table 1. Identification of the most differentially expressed proteins on Lomentospora prolificans cells exposed to voriconazole.
Spot
No.
Ratio NCBI No. Protein name Orthologous to Matching
peptides
Sequence
coverage (%)
MASCOT
score
1 3.365
("VRC)
gi|666870829 Heat shock 70 kDa protein Scedosporium
apiospermum
24 18 941
2 2.504
("VRC)
gi|666862145 Glutamate dehydrogenase-like protein
(hypothetical protein SAPIO_CDS10451)
Scedosporium
apiospermum
23 39 1073
3 2.312
("VRC)
gi|666870829 Heat shock 70 kDa protein Scedosporium
apiospermum
16 19 836
4 0.350
(#VRC)
gi|666862378 60S ribosomal protein-like protein
(hypothetical protein SAPIO_CDS9923)
Scedosporium
apiospermum
13 10 286
5 0.322
(#VRC)
gi|310798588 RNA recognition domain-containing
protein
Colletotrichum graminicola
M1.001
12 22 358
gi|576039574 Malate dehydrogenase-like protein Chaetomium thermophilum
var. thermophilum DSM
1495
10 30 302
gi|88766385 G-protein β subunit Metarhizium anisopliae 11 19 300
6 0.285
(#VRC)
gi|666862378 60S ribosomal protein-like protein
(hypothetical protein SAPIO_CDS9923)
Scedosporium
apiospermum
23 13 292
7 0.231
(#VRC)
gi|380482569 Glyceraldehyde-3-phosphate
dehydrogenase
Pestalotiopsis fici W106-1 12 21 411
gi|666862386 D-arabinitol dehydrogenase-like protein
(hypothetical protein SAPIO_CDS9932)
Scedosporium
apiospermum
24 28 408
8 Unique in
VRC
gi|302912421 Srp1 family-like protein (hypothetical
protein NECHADRAFT_102628)
Nectria haematococca
mpVI 77-13-4
47 42 572
https://doi.org/10.1371/journal.pone.0174885.t001
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antifungal drug activities [21]. However, up to now clinical results are not satisfactory and con-
sequently there is an urgent need for novel therapeutic approaches that help to eliminate the
fungus. Therefore, since the molecular basis of this species multidrug resistance is completely
unknown, the aim of this work was to analyze the changes on L. prolificans cells when exposed
to the antifungal drug VRC.
First, we observed by microscopy that while fungal germination rate did not alter after VRC
exposure at any concentration assessed, hyphal morphology was dramatically modified with
cells being significantly shorter and thicker when exposed to the antifungal drug. Moreover,
calcofluor white staining showed that VRC-treated cells emitted a more intense fluorescence,
this has been linked previously to an increase in chitin content [22]. These findings indicate
that VRC could bring about changes in the fungal cell wall that may be associated with L. proli-
ficans resistance.
Therefore, we looked deeper into the alterations in the structure and composition of the
cell wall after exposure to VRC. Interestingly, using electron microscopy we determined that
in L. prolificans, while the inner layer of this organelle did not significantly change, the thick-
ness of the outer fibrillar layer after VRC exposure increased almost three times. In this
respect, similar observations have been reported in A. fumigatus in response to nikkomycin Z
or micafungin, either alone or in combination [23]. In addition, compositional analysis by ion
chromatography revealed that VRC-treated cells presented an overall increase in the carbohy-
drate content in the cell wall, showing significantly higher levels of rhamnose, glucosamine,
glucose, and mannose in the cell wall backbone, while in the cell surface those that increased
significantly were galactose, glucose, and mannose. Remarkably, these alterations may be
related to an increased presence of carbohydrate polymers, such as chitin, α- or β-glucans, and
(rhamno)-mannans, which are the main components of the cell wall structure of many fungi,
including this species [24]. As discussed previously, the increase in chitin abundance in VRC-
treated cells was also proved by calcofluor white staining. Interestingly, stimulation of chitin
synthesis in C. albicans increases echinocandin tolerance/resistance [25], and strains with
intrinsic higher abundance in this polysaccharide have been related to lower susceptibility to
these antifungal drugs [26]. However, to our knowledge, the other compositional changes
observed in this study have not so far been reported for any antifungal drug-induced effect.
Taking all these data together, it can be concluded that VRC causes dramatic changes in both
the cell wall structure and its composition, which might be due to cell membrane or wall insta-
bility promoted by the antifungal drug, as previously proposed for the effect of fluconazole on
C. albicans [17]. Membrane instability after VRC treatment was proved when L. prolificans was
grown in the presence of SDS combined with the antifungal drug. The addition of non-lethal
concentrations of the detergent to the culture medium increased the sensitivity of the fungus
to VRC, causing a loss of viability and important morphological changes in growing colonies.
In addition, the cell wall-perturbing agents calcofluor white and congo red also brought about
noteworthy changes in the colonies and viability of L. prolificans when combined with the tria-
zole. These results highlight the relevance of the fungal cell wall modifications in VRC resis-
tance and, a still unproven relation to a protective mechanism developed by the fungus to cope
with VRC, e.g. by reducing osmotic stress, or impeding and decreasing the entry of the anti-
fungal drug in L. prolificans cells.
Finally, to determine whether VRC-induced changes were occurring in whole proteomes
or cell surface-associated proteins, a proteomics-based study of L. prolificans was per-
formed. Over the last few years, these approaches have been helpful in identifying both
novel and specific targets, and to describe the molecular interactions between drugs and
fungi, as previously reported for C. albicans [17,27], Cryptococcus gattii [28], or Aspergillus
fumigatus [29,30]. Surprisingly, our results showed no significant differential protein
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abundance between VRC-treated and non-treated cell whole proteomes. This unexpected
finding may be due to several factors, including some related to the experimental paradigm
used in this study or to limitations in the proteomic approach employed, which might ham-
per the detection of low-abundant proteins. On the contrary, a total of seventy two protein
spots were found, either up- or down-regulated, when only cell surface subproteomes were
scrutinised. Among these, Hsp70 (in two protein spots), glutamate dehydrogenase-like pro-
tein, and a Srp1 family-like protein (unique in VRC-induced subproteome), were identified
as up-regulated; and 60S ribosomal protein-like protein (in two protein spots), and two pro-
tein spots which could only be identified as a mixture of proteins, as down-regulated. The
fact that protein identification had to be carried out by searching against orthologous
sequences available in the databases may have hampered a more accurate identification of
these proteins.
The interest in heat shock proteins (HSP), especially Hsp90, as antifungal targets has risen
in the last years [31]. Beyond their role as chaperones to stabilize other protein structures in
thermal shock conditions, HSPs have been related to the orchestration of antifungal drug resis-
tance, or tolerance, under the regulation of calcineurin, which has many roles in fungal cell
growth, virulence, and stress resistance [32]. In fact, Hsp70, which is also involved in the
abovementioned Hsp90-calcineurin pathway, has recently been associated with amphotericin
B and caspofungin resistance in A. terreus and A. fumigatus, respectively [33,34]. Therefore,
our results are in accordance with these recent reports, suggesting that this protein could be
significant in L. prolificans VRC resistance. Furthermore, this protein has been identified pre-
viously as an important L. prolificans antigen that is recognised by immunocompetent individ-
uals, by both immunoglobulin (Ig) A and G, and is one of the most abundant and
seroprevalent antigens [18,35,36].
On the other hand, a putative Srp1 protein was identified, this protein spot being only
detected in VRC-treated cells. Although little is known about these proteins, they are putative
suppressors of RNA polymerases [37], which are normally located in the nuclear membrane.
However, they have been also detected in the fungal cell wall [38] and linked to cell thermal
stress [39]. Regarding the 60S ribosomal proteins that were found down-regulated upon VRC
exposure, these are involved in protein translation, as structural parts forming ribosomes.
Interestingly, they have been associated with antifungal stress by either being down- [40] or
over-expressed [28], which may be due to differences in the mechanisms pathways of action
used by the drugs. It is worth highlighting the fact that both Srp1 and 60S ribosomal proteins
are related to protein synthesis, and may be related to the morphological changes occurring in
L. prolificans cells in response to VRC. Finally, proteins related to amino acids such as gluta-
mate dehydrogenase, and the carbohydrate metabolism (such as malate dehydrogenase, in the
protein spots with a mixture of proteins) have been found to be differentially down-regulated,
showing that the fungal cell is regulating its own metabolism.
In summary, the present work has extensively analysed the biological responses of L. prolifi-
cans in the presence of VRC, above all focusing on the molecular changes occurring in the fun-
gal cell wall. Precisely, changes in cell shape after exposure to VRC have been described, L.
prolificans forming shorter and wider cells compared to untreated ones. Moreover, crucial
modifications in the cell wall structure and carbohydrate composition have also been noted,
the fungus building a thicker cell wall with a higher level of glucans and mannans, among
other carbohydrates. In addition, several CSP were also found to be altered, showing the rele-
vance of Hsp70 and Srp1 as they were identified as the most overexpressed proteins after VRC
exposure. Targeting these processes or specific proteins may be helpful for the development of
novel and effective therapies against mycoses caused by L. prolificans, improving the health of
the patients suffering from them.
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Supporting information
S1 Fig. Susceptibility of Lomentospora prolificans to cell membrane- and wall-disturbing
agents. Decimal dilutions of conidial suspensions were spotted onto potato dextrose agar
plates containing 0, 100, 250, 500, 750 or 1000 μg/ml of SDS, calcofluor white (CFW) or congo
red (CR).
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